Launched in 2014 by Glen Tullman, Livongo was founded to empower people with chronic conditions to live better and healthier lives, beginning with diabetes. More than six years later, Livongo has gone above and beyond its initial offering to help people around the country manage numerous chronic conditions. And in July 2019, Livongo went public, marking the largest digital health IPO ever. Most recently, the company announced a merger with Teledoc, valuing the company at $18.5B and becoming the largest consumer digital health merger in history.
From the start, there was demand for Livongo’s solutions from large, self-insured employers, frustrated by years of increasing costs, and from health consumers who were unhappy with existing solutions. By the time the company raised its Series C $44.5 million round in 2016, it was clear that Livongo’s solution worked and clients were eager to pay for it. In fact, two days after the company’s devices received clearance from the FDA, thousands of orders were placed.
Sapphire Ventures is proud to have participated in Livongo’s Series C fund raise, and since then, has partnered with Glen and the team to help place several key executives, facilitate meaningful business introductions and drive awareness for Livongo and its mission to improve the health and living conditions for meaningful sections of the population. We are so excited by Livongo’s journey and our partnership that we captured our journey together in the following case study.
Read the case study here
